S. Durupt

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Pierre‐Régis Burgel, À. Munck, I. Durieu et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 127 citations

Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study

I. Durieu, Olivier Pellet, Laurent Simonot et al. · Journal of Hepatology · 1999 · 83 citations

Primary Sclerosing Cholangitis, Biliary Disorder, Cholangiopathies +2

Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of Nocardiosis

Claire Rouzaud, Verónica Rodríguez-Nava, Émilie Catherinot et al. · Journal of Clinical Microbiology · 2018 · 79 citations · Full text

Pregnancy outcome in women with cystic fibrosis and poor pulmonary function

Quitterie Reynaud, Christine Rousset‐Jablonski, S. Poupon-Bourdy et al. · Journal of Cystic Fibrosis · 2019 · 46 citations · Full text

Maternal Cardiovascular Outcome, Maternal Complication, Poor Pulmonary Function +12